CMEdiscovery.com
inflammatory aspects vulnerable plaque
home faculty accreditation program monograph posttest contact

Chair

Peter Libby, MD Peter Libby, MD
Mallinckrodt Professor of Medicine
Harvard Medical School
Chief, Cardiovascular Medicine
Brigham and Women's Hospital

Peter Libby, MD, is the Chief of Cardiovascular Medicine at the Brigham and Women’s Hospital in Boston, Massachusetts. He also serves as the Mallinckrodt Professor of Medicine at Harvard Medical School. Dr. Libby directs the D.W. Reynolds Cardiovascular Clinical Research Center at Harvard. His current major research focus is the role of inflammation in vascular diseases such as atherosclerosis. Dr. Libby has received numerous awards and recognitions for his research accomplishments, including the 2006 Distinguished Scientist Award of the American College of Cardiology. His areas of clinical expertise include general and preventive cardiology.

An author and lecturer on cardiovascular medicine and atherosclerosis, Dr. Libby has published extensively in medical journals including Circulation, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences, New England Journal of Medicine, and Nature. He is Editor-in-Chief of the coming edition of Braunwald’s Heart Disease. Dr. Libby has also contributed the chapters on the pathogenesis, treatment, and prevention of atherosclerosis to Harrison’s Principles of Internal Medicine. He has held numerous visiting professorships and has been selected to deliver over 50 named or keynote lectures throughout the world.

Dr. Libby’s professional memberships include the Association of American Physicians, the American Society for Clinical Investigation, and honorary membership in the British Atherosclerosis Society. He currently serves as the President of the Association of University Cardiologists. He has served in many roles as a volunteer for the American Heart Association, including chairman of several research committees and member of the executive committees of the Councils on Arteriosclerosis, Circulation, and Basic Science. He has frequently served as a consultant to the National Heart, Lung, and Blood Institute (NHLBI), including a 5-year term on the Board of Scientific Councilors. He was the recipient of a MERIT Award from the NHLBI.

Dr. Libby earned his medical degree at the University of California, San Diego, and completed his training in internal medicine and cardiology at the Peter Bent Brigham Hospital (now Brigham and Women’s Hospital). He also holds an honorary MA degree from Harvard University.


Faculty

John Cooke, MD, PhD John Cooke, MD, PhD
Professor of Medicine
Stanford University School of Medicine

A nationally recognized figure in endothelial biology, Dr. Cooke trained in Cardiovascular Medicine at the Mayo Clinic and obtained his Ph.D. in physiology there. Subsequently, he was recruited to Harvard Medical School as an Assistant Professor of Medicine. In 1990, Dr. Cooke was recruited to Stanford University to spearhead the program in Vascular Biology and Medicine. In that year, Dr. Cooke was one of two individuals selected by the National Institutes of Health to develop national centers of excellence in Vascular Medicine. Dr. Cooke is Director of the Vascular Biology and Medicine Program at Stanford and the Clinical Research Group in Vascular Medicine. This is a well-funded research group with grants from the National Institutes of Health, the American Heart Association, and industry. Dr. Cooke has published over 250 articles on topics of vascular medicine and biology as well as a textbook in vascular medicine. His research focuses on endothelial biology, specifically the role of NO synthase in angiogenesis and atherosclerosis. In addition to conducting a successful program of bench to bedside research in vascular biology and medicine, Dr. Cooke is a sought-after consultant to government and industry and has served on numerous national and international committees that deal with cardiovascular diseases, including those of the American Heart Association, American College of Cardiology and the National Heart, Lung and Blood Institute. He provides guidance to biotechnology, device and pharmaceutical firms regarding their basic and clinical research directions in vascular biology and medicine. Dr. Cooke has special expertise in development of agents for peripheral arterial disease, and is a member of the Vascular Trialists, a group of clinician-investigators with particular interest in formulating and executing trials for testing novel therapies for PAD.


Antonius F. W. van der Steen, PhD

Antonius F. W. van der Steen, PhD
Head Biomedical Engineering
Thorax Centre
ErasmusMC, Rotterdam

A.F.W. (Ton) van der Steen (M 1994, SM 2003) is Professor in Biomedical Engineering in Cardiology. He has an MSc in Applied physics (1989, Technical University Delft) and a PhD in Medical Science (1994, Catholic University Nijmegen). Since 1994 he is connected to the Thorax Centre and the Interuniversity Cardiology Institute of the Netherlands. He is head Biomedical Engineering of the Thorax Centre, ErasmusMC. His expertise is mainly in diagnostic cardiologic imaging devices with emphasis on echography. Current research interests are focused to vulnerable atherosclerotic plaque detection, ultrasound contrast agents, ultrasound transducer design and hemodynamics. His research on vulnerable plaque detection has resulted in many publications and several patents on IVUS flow, IVUS palpography, harmonic IVUS and vasa vasorum detection.


Medical Writer

Wendy Gloffke, PhD



Disclosure Policy

It is the policy of ArcMesa Educators to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/authors are expected to disclose any relevant financial relationships they may have with commercial interests in relation to this activity. These relationships, along with the educational content of this program, have been reviewed and any potential conflicts of interest have been resolved to the satisfaction of ArcMesa Educators.

Faculty Disclosure Declarations

Peter Libby, MD– Consultant, Speakers' Bureau: AstraZeneca, Bristol-Myers Squibb, Merck & Co., Inc, Novartis, Pfizer, and Sanofi-Aventis; Consultant: Interleukin Genetics, Schering Plough, and GlaxoSmithKline

John Cooke, MD, PhD– Speaker's Bureau: Bristol-Myer Squibb; Grant Support: Genentech; Stock: Athenager; Research Support: Genzyme and Ciphergen

Antonius F. W. van der Steen, PhD– Research Support: Volcano Corp, Boston Scientific, LightLab, BMS Imaging

Wendy Gloffke, PhD– Nothing to disclose





Printer settings may vary. Please use landscape layout option.



CMEdiscovery.com
Copyright © 2006 ArcMesa Educators / CMEdiscovery.com. All rights reserved.